BRITTANY REED: Open Payments
NPI 1649926270 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,264 in 117 payments from 24 companies in 2025. Trend: 2023 $2,202 · 2024 $2,284 · 2025 $2,264
Food & beverage: $2,202Education: $62
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $444 |
| Galderma Laboratories, L.P. | 19 | $293 |
| Lilly USA, LLC | 15 | $282 |
| Regeneron Healthcare Solutions, Inc. | 5 | $164 |
| UCB, Inc. | 7 | $157 |
| Amgen Inc. | 11 | $154 |
| REVANCE THERAPEUTICS, INC. | 1 | $143 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $71 |
| Janssen Biotech, Inc. | 3 | $71 |
| Mallinckrodt Hospital Products Inc. | 3 | $67 |
Products named: TALTZ, SKYRIZI, DUPIXENT, RINVOQ, NEMLUVIO, Bimzelx, OTEZLA, DAXXIFY.
Industry payments across MO — which companies pay providers there.
